Engineering Technologies and Clinical Translation (notice n° 1330206)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02872cam a2200289zu 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | FRCYB88965474 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250429183819.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 250429s2021 fr | o|||||0|0|||eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780323909495 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | FRCYB88965474 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | FR-PaCSA |
Language of cataloging | en |
Transcribing agency | |
Description conventions | rda |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Amiji Phd, Mansoor M. |
245 01 - TITLE STATEMENT | |
Title | Engineering Technologies and Clinical Translation |
Remainder of title | Volume 3 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy |
Statement of responsibility, etc. | ['Amiji Phd, Mansoor M.', 'Milane Phd, Lara Scheherazade'] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Name of producer, publisher, distributor, manufacturer | Academic Press |
Date of production, publication, distribution, manufacture, or copyright notice | 2021 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | p. |
336 ## - CONTENT TYPE | |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type code | c |
Source | rdamdedia |
338 ## - CARRIER TYPE | |
Carrier type code | c |
Source | rdacarrier |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Engineering Technologies and Clinical Translation: Volume 3: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy examines the challenges of delivering immuno-oncology therapies, focusing specifically on the development of solutions for drug delivery and its clinical outcomes. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited. This volume of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy discusses biomaterial, microfluidic, and biodegradable devices, engineered microbes, personalized medicine, clinical approval process, and many other IO technologies. Engineering Technologies and Clinical Translation: Volume 3: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side. - Explores engineering technologies and their clinical translation in a comprehensive way - Presents forecasting on the future of nanotechnology and drug delivery for IO - Engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | |
700 0# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Amiji Phd, Mansoor M. |
700 0# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Milane Phd, Lara Scheherazade |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Access method | Cyberlibris |
Uniform Resource Identifier | <a href="https://international.scholarvox.com/netsen/book/88965474">https://international.scholarvox.com/netsen/book/88965474</a> |
Electronic format type | text/html |
Host name |
Pas d'exemplaire disponible.
Réseaux sociaux